Delivery Order SPE2DB24D2102-SPE2DB26FJHLE
Award Date 10/17/25
Potential Completion Date 10/20/25
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $9,627.61 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Mesalamine 800 mg delayed-release tablets in a quantity of 180 units. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a $17,412.86 delivery order to AmerisourceBergen Drug Corp for 180 tablets of Mesalamine 800 mg delayed-release medication, with an ultimate completion date of July 29, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $1,286.99 to AmerisourceBergen Drug Corp for 120 tablets of Mesalamine DR 1.2 GM on August 15, 2025, with completion targeted for August 18, 2025. This firm fixed price delivery order represents a non-set-aside award issued under competitive procurement procedures. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine 800 mg delayed-release tablets (180-count) under a firm fixed-price contract. The order, valued at $40,028.47, is scheduled for completion by April 28, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,803.07 on September 15, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120 count). This is a firm fixed-price, non-set-aside contract with performance based in Conshohocken, Pennsylvania, and an ultimate completion date of September 16, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Mesalamine 800 mg delayed-release tablets (180-count units) with a ceiling value of $5,855.60. The contract, which employs firm fixed-price pricing, was competitively awarded without a set-aside designation and is scheduled for completion by September 10, 2025. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania, the company's headquarters location. This...
- The Defense Logistics Agency awarded a $6,571.87 delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine 800 mg delayed-release tablets (180-count supply) with a completion date of September 8, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Mesalamine 800 mg delayed-release tablets (180-count units) under a firm fixed-price contract valued at $2,968.38. This non-set-aside, competitively awarded delivery order is scheduled for completion by October 16, 2025, with performance at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role...
- The Defense Logistics Agency (DLA) awarded a $1,694.97 delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count unit) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $14,506.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine 1.2GM (120 count) with an ultimate completion date of October 15, 2025. The award, issued on September 17, 2025, was competitively awarded with no set-aside designation. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...